Global Valsartan-Hydrochlorothiazide Market Growth 2018-2023

Global Valsartan-Hydrochlorothiazide Market Growth 2018-2023

Pharmaceuticals 23/11/2018 164 List Figures TOC

This drug is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains two medications: valsartan and hydrochlorothiazide. Valsartan is an angiotensin receptor blocker (ARB) and works by relaxing blood vessels so that blood can flow more easily. Hydrochlorothiazide is a "water pill" (diuretic) that causes you to make more urine, which helps your body get rid of extra salt and water.

According to this study, over the next five years the Valsartan-Hydrochlorothiazide market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Valsartan-Hydrochlorothiazide business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Valsartan-Hydrochlorothiazide market by product type, application, key manufacturers and key regions and countries.

This study considers the Valsartan-Hydrochlorothiazide value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.
80mg/12.5mg
160mg/12.5mg
320mg/12.5mg
160mg/25mg
320mg/25mg
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 11.8.
Hospital
Drug store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Teva
Lupin
Aurobindo Pharma
Torrent Pharmaceuticals
Par Pharmaceutical
Huaren Pharmaceutical
Mylan
Alembic Pharmaceuticals
Zhejiang Huahai Pharmaceutical
APOTEX
MACLEODS
Chongqing Conquer Pharmaceutical
Beijing Second Pharmaceutical
Cisen Pharmaceutical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Valsartan-Hydrochlorothiazide consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Valsartan-Hydrochlorothiazide market by identifying its various subsegments.
Focuses on the key global Valsartan-Hydrochlorothiazide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Valsartan-Hydrochlorothiazide with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Valsartan-Hydrochlorothiazide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.